Sr. Director, Internal Audit
![]() | |||
![]() United States, Massachusetts, Cambridge | |||
![]() 675 West Kendall Street (Show on map) | |||
![]() | |||
Senior Director, Internal Audit
Overview As the Senior Director, Internal Audit, you will play a pivotal role in the continued growth of a dynamic internal audit function for a leading biopharmaceutical company. The ideal candidate will have strong auditing and biotech / pharma industry experience. Integrated audit and risk-advisory experience across finance, compliance, and operations will be a big advantage. Also, experience in collaborating with, and directing external co-source partners to effectively support internal audits and SOX controls testing. This role requires excellent communications and leadership skills, and the ability to work collaboratively and effectively with key stakeholders at all levels. The candidate must be eager to lead risk management and internal control improvement across the organization through thoughtful risk assessments, and the execution of complex audits and reviews in a highly regulated industry. This role will also play a crucial role in the ongoing evolution of the internal audit function to keep pace with Alnylam's growth and priorities, while conforming to the IIA standards. This is a hybrid position that requires two days on site per week in our Cambridge, MA office. This role reports to the VP, Head of Internal Audit. Key Responsibilities
Qualifications and Experience
About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. > |